Medication info
Telmicom Tablet 40/10 mg

Telmicom Tablet 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Independent Bio Pharmaceutical Co., Ltd.
Appearance
Light blue and white double-coated oval-shaped tablet with convex sides
Packaging
30 tablets/box[(10 tablets/PTP*3)], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201906243 · Approved 2019.09.03 · Insurance code 057700400

Summary

Main use
Treats essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, a direct switch to this medicine may be considered when blood pressure is not controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ○ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.
Child dose
○ Pediatric patients aged 18 years or younger: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Independent Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treats essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Used to provide additional treatment for patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of Telmisartan or Amlodipine.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, a direct switch to this medicine may be considered when blood pressure is not controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ○ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.

Child dose

○ Pediatric patients aged 18 years or younger: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication can cause serious side effects to the fetus or newborn when taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not use it. It should not be administered to patients with allergies to any of the components, severe heart disease, liver disorders, kidney disorders, and breastfeeding women. Caution is required when using this drug in patients with primary aldosteronism, certain heart valve diseases, liver disorders, gastrointestinal diseases, renovascular hypertension, hypotension, dialysis patients, and the elderly. This drug may commonly cause side effects like dizziness and peripheral edema, and serious adverse effects may occur rarely, so consultation with a healthcare professional should be sought immediately if any abnormal symptoms arise. This drug should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and switched to another safe treatment method. Since hypotension may occur, patients who are hypovolemic or hyponatremic should adjust their conditions before administration, and their blood pressure should be monitored periodically during treatment. Due to the risk of elevated potassium levels in the blood, patients with a risk of hyperkalemia should have regular blood tests. Patients with impaired kidney function should also use it cautiously while frequently checking their kidney status with blood tests. Patients with heart disease may have an increased risk of myocardial infarction or angina when using this drug, so caution is advised. This medication can cause drowsiness or dizziness when driving or operating machinery, so caution is necessary. There may be interactions with other drugs, so if currently taking other medications, it is essential to inform healthcare professionals, especially when using specific heart medications, diuretics, lithium, warfarin, non-steroidal anti-inflammatory drugs. It is safer for breastfeeding women not to take this medication. This drug is not recommended for children and adolescents under 18 years of age as its safety and efficacy have not been adequately established. Elderly patients need to be administered with adjusted dosages as they may react more sensitively to this medication. In case of overdose, symptoms like low blood pressure, dizziness, and acute renal failure may occur; immediate medical attention is required. This drug should be kept out of reach of children, and to maintain quality, it should not be transferred to other containers and should be opened just before ingestion.

Side effects

Dizziness, peripheral edema, syncope, upper respiratory infection, pharyngitis, sinusitis, urinary tract infection, cystitis, sepsis, anemia, thrombocytopenia, eosinophilia, leukopenia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, hyponatremia, hyperglycemia, depression, insomnia, mood changes, anxiety, confusion, drowsiness, headache, paresthesia, sensory loss, taste disturbance, tremor, extrapyramidal disorder, muscle rigidity, visual impairment, vertigo, tinnitus, palpitations, bradycardia, tachycardia, myocardial infarction, ventricular tachycardia, arrhythmia, atrial fibrillation, flushing, hypotension, orthostatic hypotension, cough, dyspnea, rhinitis, changes in bowel habits, diarrhea, constipation, abdominal pain, dyspepsia, nausea, vomiting, dry mouth, gum hypertrophy, abdominal discomfort, pancreatitis, gastritis, liver dysfunction, liver disorder, hepatitis, jaundice, elevated liver enzymes, pruritus, hyperhidrosis, rash, hair loss, purpura, skin discoloration, eczema, erythema, angioedema, toxic skin rash, drug rash, urticaria, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, photosensitivity reaction, joint swelling, muscle cramps, arthralgia, myalgia, low back pain, limb pain, tendon pain, renal dysfunction, urinary disorders, frequency of urination, nocturia, erectile dysfunction, gynecomastia, edema, weakness, fatigue, chest pain, malaise, influenza-like illness, elevated liver enzymes, increased blood creatinine, weight gain, weight loss, increased blood uric acid, increased blood creatine phosphokinase, decreased hemoglobin, vasculitis, interstitial lung disease, interstitial pneumonia, eosinophilic pneumonia, hepatocellular carcinoma, cerebral infarction, congestive heart failure, musculoskeletal pain, neck pain, nasopharyngitis, upper abdominal discomfort, upper abdominal pain, positional dizziness, hypotension, tachycardia, acute renal failure, excessive peripheral vasodilation, reflex tachycardia, systemic hypotension, shock state, shock, delayed-type non-cardiogenic pulmonary edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a tightly sealed container that blocks light. It is also recommended to store it at room temperature, between 1°C and 30°C.

Appearance and packaging

Appearance

Light blue and white double-coated oval-shaped tablet with convex sides

Package unit

30 tablets/box[(10 tablets/PTP*3)], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.